A42 (Inbrija levodopa inhalation powder 42 mg)
Generic Name: levodopa
Pill with imprint A42 is White, Capsule-shape and has been identified as Inbrija levodopa inhalation powder 42 mg. It is supplied by Acorda Therapeutics, Inc..
Inbrija is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. FDA has not classified the drug for risk during pregnancy. Inbrija levodopa inhalation powder 42 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A42
Inbrija
- Generic Name
- levodopa
- Imprint
- A42
- Strength
- levodopa inhalation powder 42 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Acorda Therapeutics, Inc.
- National Drug Code (NDC)
- 10144-0342
Related Images for "A42"
More about Inbrija (levodopa)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: dopaminergic antiparkinsonism agents
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
